NCT04615676View on ClinicalTrials.gov

Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus

CompletedOBSERVATIONAL
Enrollment

4,734

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

July 17, 2020

Study Completion Date

July 17, 2020

Conditions
SARS-CoV2
Interventions
OTHER

Follow-up phone call

Follow-up phone call after month to detect which patient have been hospitalized

Trial Locations (1)

31000

University Hospital of Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT04615676 - Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus | Biotech Hunter | Biotech Hunter